secwatch.observer — SEC 8-K summary
======================================

Issuer:     Envoy Medical, Inc. (COCH)
CIK:        0001840877
Form:       8-K
Filed at:   2026-03-27T23:59:59+00:00
Accession:  0001213900-26-035483
Event type: other_material
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Envoy Medical reports FY2025 revenue $241k; extinguishes $32M debt; completes Acclaim trial enrollment
--------------------------------------------------------------------------------

- FY2025 net revenue $241k, up from $225k (YoY +$16k). No EPS given.
- Extinguished over $32M of debt in 2025; cash $3.7M at year-end.
- FDA approved expansion of Acclaim cochlear implant pivotal trial to final stage.
- Post year-end: closed up to $78M public offering ($30M received); enrolled 56-patient pivotal trial.
- IP portfolio grew to 47 patents globally.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1840877/000121390026035483/0001213900-26-035483-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1840877/000121390026035483/ea0283065-8k_envoy.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-035483

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer